PMID: 7580874Aug 1, 1995Paper

In vivo studies on NMDA-evoked release of amino acids in the rat spinal cord

Neurochemistry International
E SundströmA Seiger

Abstract

In the present study, spontaneous and evoked release of selected amino acids in the rat spinal cord was studied using in vivo microdialysis. Perfusion of the microdialysis probe with 100 K+ evoked a 2-4-fold increase in release of the putative neurotransmitters aspartate, glutamate and taurine while glutamine was decreased. K(+)-evoked release of glutamate was almost completely Ca(2+)-dependent while that of aspartate was partially Ca(2+)-dependent. Taurine release was not affected by substituting Ca2+ with Co2+. Perfusion with 5 mM N-methyl-D-aspartate (NMDA) evoked 3-9-fold release of glutamate, glycine and taurine and a small increase in extracellular beta-alanine. No significant changes in glutamine and serine were found. 5 mM of the competitive NMDA antagonist 3-((+/-)-2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP) reduced NMDA-evoked release of glutamate and taurine by approx. 50%. 5 mM 3-amino-1-hydroxypyrrolid-2-one (HA-966), an agonist at the glycine site of the NMDA receptor with very low efficacy, completely inhibited NMDA-evoked release of taurine and reduced the levels of released glutamate below baseline, similar to the effect of 1 mM CPP alone. The present results show that in situations of excessive rele...Continue Reading

References

Jan 1, 1977·Brain Research·A Sellström, A Hamberger
Jan 1, 1991·Neuroscience·D J TraceyA Rustioni
May 1, 1991·Journal of Neurochemistry·A M Young, H F Bradford
Nov 20, 1990·European Journal of Pharmacology·F BruggerM F Pozza
Oct 27, 1987·European Journal of Pharmacology·D W BonhausJ O McNamara
Jan 1, 1989·Glia·H Pasantes-Morales, A Schousboe
Mar 1, 1989·Journal of Neuroscience Research·K H BackusM Schachner
Jan 2, 1989·Neuroscience Letters·K N WestlundR E Coggeshall
Sep 1, 1989·Pharmacology, Biochemistry, and Behavior·D B MastersB R Komisaruk
Jun 12, 1989·Brain Research·K N WestlundR E Coggeshall
Oct 1, 1989·Journal of Neurochemistry·A Schousboe, H Pasantes-Morales
Jun 1, 1989·Naunyn-Schmiedeberg's Archives of Pharmacology·B H Westerink, J B de Vries
Jun 1, 1988·Annals of Neurology·A I Faden, R P Simon
Apr 1, 1988·British Journal of Pharmacology·J H Connick, T W Stone
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D T MonaghanC W Cotman
Aug 1, 1988·Journal of Neuroscience Research·H Pasantes Morales, A Schousboe
Jan 1, 1987·Journal of Neuroscience Research·S S Oja, P Kontro
Oct 1, 1983·Journal of Neurochemistry·U TossmanU Ungerstedt
Aug 30, 1994·Proceedings of the National Academy of Sciences of the United States of America·H LiuA I Basbaum
Oct 15, 1993·Science·T SmirnovaJ Mallet
Aug 10, 2010·Brain : a Journal of Neurology·Marieke BiegstraatenIvo N van Schaik

❮ Previous
Next ❯

Citations

Aug 26, 2003·Advanced Drug Delivery Reviews·Carl-Olav StillerErnst Brodin
Aug 14, 1999·Brain Research. Brain Research Protocols·H GustafssonE Brodin
Mar 15, 2002·Journal of Neurotrauma·Erik Sundström, Li-Li Mo
Nov 5, 1997·Synapse·W Timmerman, B H Westerink

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.